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Murine animal models from genetically modified pluripotent stem cells (PSCs) are essential
for functional genomics and biomedical research, which require germline transmission for the
establishment of colonies. However, the quality of PSCs, and donor-host cell competition in
chimeras often present strong barriers for germline transmission. Here, we report efficient
germline transmission of recalcitrant PSCs via blastocyst complementation, a method to
compensate for missing tissues or organs in genetically modified animals via blastocyst
injection of PSCs. We show that blastocysts from germline-deficient Prdm14 knockout rats
provide a niche for the development of gametes originating entirely from the donor PSCs
without any detriment to somatic development. We demonstrate the potential of this
approach by creating PSC-derived Pax2/Pax8 double mutant anephric rats, and rescuing
germline transmission of a PSC carrying a mouse artificial chromosome. Furthermore, we
generate mouse PSC-derived functional spermatids in rats, which provides a proof-of-
principle for the generation of xenogenic gametes in vivo. We believe this approach will
become a useful system for generating PSC-derived germ cells in the future.
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Genetically engineered animals provide essential insightsinto in vivo gene function and human genetic disorders.Pluripotent stem cells (PSCs) have been routinely used
for targeted gene manipulation, particularly in rodents. PSCs
can form all the tissues of the body, including the germline.
Upon injection into the morula/blastocyst stage embryos, PSCs
can carry their genetic modification to the next generation via
germline transmission. While recent progress in genome edit-
ing technologies such as CRISPR/Cas9 in zygotes have enabled
the generation of desired animals rapidly and efficiently1,2,
PSCs are useful for precise genetic modifications3. Introduction
of point mutations or genes of interest via gene targeting and
complex cell-based genetic modifications, such as microcell-
mediated chromosome transfer, rely on PSCs4,5. However,
germline transmission of the genetic modifications by chimer-
ism with PSCs can be variable and inefficient, partly because of
the competition between the host and donor cells in chimeras
that are affected by the quality of PSCs. An experimental
approach that results in predictable functional gametes with
desired genotypes from PSCs more efficiently is highly desir-
able. Here we apply the blastocyst complementation method
to overcome the variable germline transmission of genomic
modifications.
Blastocyst complementation can be used to generate a tissue or
organ from donor PSCs in genetically modified animals. For
example, injection of PSCs into blastocysts derived from animals
that are unable to make certain tissues or organs allows donor
PSCs to develop and compensates for the missing tissues or
organs in chimeric animals. So far, other groups and we, have
demonstrated the successful generation of several organs, such as
the pancreas, thymus, kidney, liver, brain, and lung by blastocyst
complementation6–12. Such an approach is also possible in an
interspecific setting between the mouse and rat6,10,12. If the same
strategy can be applied to the germline using germline-deficient
animals, PSCs could develop efficiently as gametes even when the
quality of PSCs is not optimum.
For a suitable host blastocyst lacking the germline, we focused
on Prdm14, a key transcriptional regulator essential for the spe-
cification of primordial germ cells (PGCs), the founder cells for
gametes. In rodents, a lack of Prdm14 causes loss of PGCs during
development, which subsequently leads to infertility both in
males and females. Importantly, the development of other organs
and tissues is not impaired in these mutants13,14. Therefore,
Prdm14-deficient animal could serve as an appropriate host for
the derivation of germ cells from donor PSCs.
Here, we demonstrate efficient germline transmission of
PSCs via blastocyst complementation using germline-deficient
Prdm14 knockout (KO) rats14. The rat is an important organ-
ism for physiological and pharmacological modeling of human
diseases15. Achieving appropriate culture conditions to main-
tain germline-competent rat embryonic stem cells (ESCs) has
enabled generation of genetically modified rat. 16–19. However,
rat PSCs are less robust than mouse PSCs, partly because of the
difficulties of handling and clonal selection after genetic
manipulation20,21. Besides, rat PSCs exhibit rapid loss of
genomic imprints in culture, which affects their developmental
potential, as judged by tetraploid complementation experiments
designed to produce an entirely PSC-derived animal22,23. Here,
we show that the use of rat blastocyst from Prdm14 KO rats
serve as excellent hosts for the germline transmission of donor
cells. We use our method to demonstrate the production of a
double mutant rat line, and rescue of germline transmission of
PSCs with a mouse artificial chromosome (MAC). Finally, we
also show the derivation of viable mouse gametes using the
Prdm14 KO rat host blastocysts.
Result
Blastocyst complementation using Prdm14 KO rats enables
efficient germline transmission of allogenic embryonic stem
cells (ESCs). First, we tested if host Prdm14 KO rat embryos
lacking germ cells permit the efficient contribution of exogenous
rat PSCs to the germline. For this, we collected Prdm14 KO rat
blastocysts, by crossing Prdm14HV/+ with Prdm14mut/+ rats
(both with albino coat color: Fig. 1a). We selectively used
Prdm14-H2BVenus positive blastocysts (Prdm14HV/+ or
Prdm14mut/HV) to track Prdm14, since it is highly expressed in
the inner cell mass of the rat blastocysts14. For donor rat PSCs, we
used male and female rat ESCs (black coat color) ubiquitously
expressing tdTomato established from homozygous Rosa26-
tdTomato knock-in rats24 (see “Methods”). After injecting ESCs
into Prdm14-H2BVenus positive blastocysts, we transferred them
into the uteri of foster mothers and analyzed their contribution
towards the germline in the adults (Fig. 1b). In the Prdm14
heterozygous host (Prdm14HV/+) where germ cells develop nor-
mally akin to wildtypes, rat ESCs contributed to somatic lineages
and the germline depending on the extent of chimerism (Fig. 1c,
d, Supplementary Table 1). After crossing with wild-type rats, a
small proportion of offspring showed tdTomato fluorescence and
dark skin (male: 16/174 [9.2%], female: 10/87 [11%], Fig. 1g,
Supplementary Fig. 1a, Table 1, Supplementary Table 1), sug-
gesting that germline transmission of donor rat ESCs occurred
only in some neonatal rats. In contrast, in the Prdm14 KO host
(Prdm14mut/HV), rat ESCs contributed to somatic lineages like in
the Prdm14 heterozygous rat, but all the germ cells in sex-
matched chimeras showed tdTomato fluorescence (Fig. 1e, f,
Supplementary Table 1). Whereas, the Prdm14 KO host has
impaired PGC specification and development, and does not show
any detectable germline contribution. Notably, all the next gen-
eration rats obtained after crossing with wild-type rats exhibited
tdTomato fluorescence and dark skin (male: 85/85 [100%], female
(31/31 [100%], Fig. 1h, Supplementary Fig. 1a, b, Table 1, Sup-
plementary Table 1), suggesting complete germline transmission
of donor rat ESCs without any host-derived germ cells. Collec-
tively, we find that blastocyst complementation using host
Prdm14 KO rat blastocysts enabled efficient germline transmis-
sion of donor rat ESCs.
Efficient production of genetically modified rats using blas-
tocyst complementation in the germline. Next, we investigated
whether blastocyst complementation in the germline is a viable
tool to generate genetically modified rats efficiently. To demon-
strate this, we used Pax2/Pax8 double mutant rat ESCs as donor
cells to obtain double KO rats. Both Pax2 and Pax8 are tran-
scriptional regulators important for the proliferation and differ-
entiation of multiple cell types, particularly in the kidney25,26.
Importantly, the Pax2/Pax8 double KO mice show a complete
lack of kidneys as well as ureters. Sall1 KO animals are the closest
anephric model for the Pax2/Pax8 double KO mice, lacking renal
parenchyma; however, they retain ureters7,10. Generating double
KO’s using the conventional method, by crossing heterozygous
mutants is highly inefficient with KO’s expected at a 1/16 Men-
delian ratio. Thus, here we applied blastocyst complementation in
the germline for efficient generation of Pax2/Pax8 double
mutant rats.
We first screened male and female Rosa26-tdTomato rat ESC
lines that have a frameshift mutation in Pax2 and Pax8
coding sequences created with the CRISPR/Cas9 system
(Supplementary Fig. 2). Then, we injected them into
Prdm14HV/+ or Prdm14mut/HV blastocysts (Fig. 2a). While
donor ESCs lacking Pax2/Pax8, are expected not to form the
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kidney, the chimeras grew into normal adults without any
impairment, suggesting host-derived cells developmentally
rescued the defect. Indeed, the chimeras exhibited a lack of
contribution of Pax2/Pax8 KO cells to renal lineages, including
the ureters (Fig. 2b, Supplementary Fig. 2b–d). In contrast, all
the germline in testes and ovaries of Prdm14 KO rats are
composed of tdTomato expressing cells (Fig. 2b), confirming
our previous result (Fig. 1), that the germline is complemented
by donor Pax2/Pax8 KO rat ESCs. Next, we crossed male and
female chimeras with Pax2/Pax8 KO gametes to obtain Pax2/
Pax8 double KO rats. As expected, all the offspring lacked
kidneys and ureters (Fig. 2c, Table 1). Thus, we could efficiently
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To further demonstrate the potential of blastocyst comple-
mentation via the germline and compare with available methods
to produce genetically modified animals, we next used a rat ESC
line carrying a MAC. MAC is an exogenous chromosome capable
of replicating and segregating as an independent chromosome27.
MAC is a useful tool for creating humanized model rodents that
recapitulate human disorders. MACs inserts are several megabase
long sequences, which cannot be achieved by conventional
embryonic transgenesis approaches28. Technically, the introduc-
tion of MAC requires cell-based transgenesis using PSCs or male
germline stem cells27,29. Thus, the successful production of the
MAC carrying animals relies mainly on the quality of the cells.
Here, we used male rat ESCs carrying a MAC containing EGFP
expression cassette (Fig. 2a, d). When we injected the MAC rat
ESCs into wild-type or Prdm14 heterozygous rat blastocysts, we
were unable to obtain any chimeras showing signs of germline
contribution of the MAC rat ESCs in the testes, despite testing
over 50 sex-matched chimeras (Table 1). While most of them
showed EGFP fluorescence in the testis (Fig. 2e), only the somatic
cells surrounding the germ cells were EGFP-positive in the
sections (Fig. 2f), indicating that the MAC rat ESC line we used in
this study shows almost no germline contribution. In contrast, in
chimeras obtained from Prdm14 KO rat blastocysts, we could
observe seminiferous tubules filled with EGFP-positive cells in the
adult testes (Fig. 2e). The tubules contained male germ cells at all
stages of development, including mature spermatozoa (Fig. 2f).
To obtain the next generation carrying the MAC, we collected
and sorted EGFP-positive round spermatids from the chimeric
testes (Fig. 2g). Since expression of Prdm14-H2BVenus is absent
in adult testes of both Prdm14HV/+ and Prdm14mut/HV30, we can
selectively sort donor MAC rat ESC-derived cells from the adult
testis. Next, we performed a round spermatid injection (ROSI)
into oocytes from wild-type female rats. After embryo transfer
(ET), we successfully obtained 21 pups, and 8 of them showed
ubiquitous expression of EGFP (Fig. 2h, Table 2). All the adults
show the black eye and coat color, corresponding to the original
ESCs (Supplementary Figure 1d). Notably, EGFP-positive adult
shows a presence of the MAC in all the cells in the brain
(Supplementary Fig. 1c), suggesting that round spermatid cells
generated using Prdm14 KO blastocysts carry the MAC to the
next generation.
Generation of functional mouse spermatids in rat via inter-
specific blastocyst complementation in the germline. Next, we
investigated whether blastocyst complementation in the germline
applies to an interspecific setting between the mouse and rat. To
monitor specification and subsequent development of mouse PGCs
in rat, we used mouse ESCs established from the Blimp1-membrane
(m) EGFP reporter transgenic mouse (Blimp1Tg(BAC-mEGFP)/+), a
faithful line to monitor PGCs until gonadal stage31. The EGFP
protein in Blimp1 expressing mouse PGCs localizes at the mem-
brane. Whereas, the Venus signal in Prdm14-H2BVenus rat PGCs
is nuclear. Therefore the mouse PGCs are readily distinguishable
from rat PGCs. In addition, for visualizing the contribution to
somatic cells as well as the germline after blastocyst injection, we
introduced the CAG promoter-driven mScarlet-3xNLS (nmScarlet)
expressing vector via a PiggyBac system into mouse ESCs (Sup-
plementary Figure 3a). Upon injection of the labeled mouse ESC
line into mouse blastocysts, we confirmed their competence towards
forming chimeras and in germline transmission (Supplementary
Fig. 3b–h). We injected the mouse ESCs into Prdm14-H2BVenus
positive rat blastocysts and confirmed contribution to the germline
during development (Fig. 3a). At 6 days after ET corresponding to
embryonic day (E) 9–9.5 when rat PGCs specify, Prdm14 KO PGCs
expressing H2BVenus were detected in the posterior epiblast
(dashed line in Fig. 3b), although the rat PGCs show reduced
proliferation and fail to activate key PGC markers due to the lack of
Fig. 1 Blastocyst complementation in the germline using Prdm14 KO rat blastocysts and allogenic rat ESCs. a Collection of blastocysts after crossing
Prdm14mut/+ rats with Prdm14HV/+ rats. Prdm14-H2BVenus positive blastocysts were selectively used for subsequent blastocyst injection. b Schematics
showing injection of male (XY) or female (XX) Rosa26tdTomato/tdTomato rat ESCs into Prdm14-H2BVenus positive blastocysts. c Chimerism of coat color,
testis, and ovary in Prdm14HV/+ chimeric rats with Rosa26tdTomato/tdTomato rat ESCs. Scale bar in testis: 5 mm, in the ovary: 1 mm. d Immunohistochemical
staining of testis and ovary of chimeras in Fig.1c. Some (filled arrowheads) but not all DDX4 positive germ cells originate from tdTomato positive donor
ESCs. Scale bars: 100 μm. e Chimerism of coat color, testis, and ovary in Prdm14mut/HV chimeric rats with Rosa26tdTomato/tdTomato rat ESCs. Scale bar in
testis: 5 mm, in the ovary: 1 mm. f Immunohistochemical staining of testis and ovary of chimeras in Fig.1e. All the DDX4 positive germ cells originate from
tdTomato positive donor ESCs. Scale bars: 100 μm. g Offspring obtained by crossing Prdm14HV/+ chimeric rats with wild-type Crlj: WI rats. Ubiquitous
tdTomato expression shows successful germline transmission of injected Rosa26tdTomato/tdTomato rat ESCs. h. Offspring obtained by crossing Prdm14mut/HV
chimeric rats with wild-type Crlj: WI rats. All the neonates ubiquitously expressed tdTomato indicating perfect germline transmission of Rosa26tdTomato/
tdTomato rat ESCs.
Table 1 Blastocyst injection and germline transmission of ESCs.
Donor PSC Prdm14 genotype in
host embryo
No. (%) of injected
embryos
No. (%) of pups No. of live sex-
matched chimeras
Cell type Genotype Gender Transferred Full-term Analyzed Chimeras Analyzed KO GT
Rat ESC Rosa26tdTomato/tdTomato XY KO or Hetero 65 33 (51) 31 24 (77) 14 3 2
Rat ESC Rosa26tdTomato/tdTomato XX KO or Hetero 78 30 (38) 30 15 (50) 9 4 3
Rat ESC Pax2/Pax8 KO XY KO or Hetero 173 69 (40) 67 33 (49) 17 9 9
Rat ESC Pax2/Pax8 KO XX KO or Hetero 254 126 (50) 126 37 (29) 15 12 5b
Rat ESC MAC XY WT or Heteroa 218 132 (61) 132 112 (85) 53 – 0
Rat ESC MAC XY KO or Hetero 22 18 (82) 18 16 (89) 7 5 5
Mouse ESC Blimp1Tg(BAC-mEGFP)/+/
CAG-nmScarlet
XY KO or Hetero 32 17 (53) 17 9 (53) 6 3 2
Mouse iPSC CAG-EGFP XY KO or Hetero 44 17 (39) 17 9 (53) 6 2 2
aWildtype or Prdm14-H2BVenus negative (Prdm14mut/+ or Prdm14+/+) blastocysts were used as the control experiments.
bWe tested 5 out of 12 Prdm14HV/mut (KO) chimeras for the germline transmission.
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Prdm1432. Strikingly however, Blimp1-mEGFP/CAG-nmScarlet
positive cells were also observed in the PGC cluster, suggesting that
the rat environment is conducive for mouse ESC-derived PGC
specification (Fig. 3b). At 12 days post ET (E15-15.5), mouse PGCs
were undetectable in Prdm14 heterozygous rat gonads, although
nmScarlet positive somatic cells surrounding rat PGCs were present
(Supplementary Fig. 4b). In contrast, Blimp1-mEGFP/CAG-
nmScarlet positive mouse PGCs expressing DAZL, a key gonadal
PGC marker, colonized Prdm14 KO rat gonads normally devoid of
rat PGCs (Fig. 3c, Supplementary Fig. 4b). The somatic contribu-
tion of mouse ESCs in rats is, however, not as high as in mice




















































































































































































NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21557-x ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1328 | https://doi.org/10.1038/s41467-021-21557-x | www.nature.com/naturecommunications 5
two out of three testes showed nmScarlet expression within the
seminiferous tubules, and strikingly, normal spermatogenesis could
be observed in the section (Fig. 3d, e, Table 1). In the epididymis,
we could also observe mature sperm with mScarlet signal in the
nucleus (Fig. 3f), but they somehow rarely show motility after being
harvested into human tubal fluid (HTF) medium suitable for mouse
sperm33. Similarly, hamster sperm also showed abnormalities when
transplanted into mouse testes34, suggesting that spermiogenesis
might be impaired in xenogeneic environments; the precise reasons
merits further considerations. To test the function of mouse ESC-
derived male germ cells generated in rats, we performed ROSI of
the FACS-sorted mouse ESC-derived round spermatid into oocytes
collected from a wild-type mouse. We successfully obtained healthy
mouse offspring, and all of them showed ubiquitous nmScarlet
expression, and almost half of them inherited Blimp1-mEGFP
transgene at a Mendelian ratio (7/20 [35.0%], Fig. 3g, Table 2)
Finally, we also tested mouse induced pluripotent stem cells
(iPSCs) from CAG-EGFP transgenic mouse6,35,36 as donor cells
for blastocyst complementation in the germline (Table 1). As with
mouse ESCs, EGFP-positive mouse iPSC-derived spermatogen-
esis was observed in Prdm14mut/HV rat testes (Fig.3h, i). Notably,
the haploid cells were able to produce viable mice after injection
into mouse oocytes (Fig. 3j). Almost half of the mice expressed
EGFP ubiquitously (16/37 [43%], Fig. 3j, Table 2), and all the
pups checked here inherited retroviral integrations of a
reprograming factor used for the establishment of iPSCs (Fig. 3k).
Taken together, we demonstrated that interspecific blastocyst
complementation in the germline can yield functional mouse
spermatids in rats.
Discussion
We demonstrate applications of blastocyst complementation in
the germline using Prdm14 KO rat embryos as hosts, with allo-
genic rat ESCs as well as xenogenic mouse ESCs as donor cells.
Since our approach allows efficient germline transmission, we
were able to produce rat lines bearing elaborate, as well as precise
genetic modifications. Lacking competition from host germ cells
unlike in conventional chimeras, our method enriches for germ
cells with desired genotypes.
By using the blastocyst complementation method, we
demonstrated the efficient generation of Pax2/Pax8 double
mutant rats lacking both renal parenchyma and ureters. For
blastocyst complementation in the kidney, we previously used
blastocysts from Sall1 KO mice or rats7,10. However, since Sall1
KO animals show defects in the renal mesenchyme but not in the
ureteric bud during renal development10,37, the ureters in the
chimera consist of both injected donor PSCs and host-derived
cells. Such contamination of host-derived tissues might prevent
efficient engraftment of PSC-derived kidneys in transplantation
therapy. Thus, for complete complementation of organs, host
lines with multiple mutations will prove beneficial in the future.
Blastocyst complementation in the germline is an effective way to
generate such elaborate genetically modified animals.
Successful germline transmission is a stringent criterion for
determining PSC pluripotency30. While mechanisms behind the
success or failure of germline transmission are not fully known,
the genetic background of the donor or host cells, chromosomal
abnormalities, or PSC sources such as those from in vitro
reprogramming are known to influence the germline
potential38,39. In our study, a rat ESC line carrying a MAC
contributed normally to somatic tissues but not to the germline in
wild-type or heterozygous animals where the host germ cells are
present. This is likely due to the clone we used since previous
reports have demonstrated successful germline transmission of
PSCs with similar artificial chromosome vectors27,28. Even when
retaining a normal karyotype, not all rat PSC lines show germline
transmission; indeed, line-to-line and clone-to-clone variations
are common21,40. Specifically, the complete lack of the host germ
cells in Prdm14 KO rat however allowed rescue of the MAC rat
ESCs, which formed functional gametes, demonstrating that the
MAC rat ESC line itself can develop as germ cells. Yet, in the
presence of host germ cells, the MAC bearing ESC-exhibit a
disadvantage since germ cells from them are competitively
eliminated from the germline. Therefore, the use of germline-
deficient animals, might also test the competency of PSCs for
Fig. 2 Generation of genetically modified rats using blastocyst complementation in the germline. a Schematics showing injection of genetically modified
rat ESCs into Prdm14-H2BVenus positive blastocysts. b Immunohistochemical staining of adult kidney, testis, and ovary in Prdm14mut/HV chimeric rats with
Pax2/Pax8 KO rat ESCs (Rosa26tdTomato/tdTomato background). While no contribution of the rat ESCs was observed in Aquaporin-1 positive proximal tubule
and Nephrin positive glomeruli in the kidney, all germ cells both in the testis and ovary originate from rat ESCs. A male ESC line and a female ESC line were
used for the testis and ovary, respectively. Both ESC lines dominantly contribute to DDX4 positive germ cells, and partially to the surrounding somatic cells
(SOX9 positive Sertoli cells or FOXL2 positive granulosa cells, respectively). Scale bars: 100 μm. c A representative picture of neonates obtained by
crossing male and female Prdm14mut/HV chimeric rats with Pax2/Pax8 KO rat ESC-derived gametes. The neonate exhibits a ubiquitous expression of
tdTomato and a complete lack of kidney. d FISH image of rat ESC carrying mouse artificial chromosome (MAC). Scale bars: 5 μm. e Testis of MAC rat ESC
chimeras. While both shows EGFP fluorescence, only the Prdm14mut/HV chimeric rat testis contains a seminiferous tubule filled with EGFP-positive MAC
rat ESC-derived germ cells. Representative seminiferous tubes of each chimera are shown in the insets. Scale bar: 5 mm. f Immunohistochemical staining of
the testis from chimera generated by injection of MAC rat ESCs into Prdm14-H2BVenus positive blastocysts. Insets show higher magnification of basal
compartments of the testis in Prdm14mut/HV chimeric rats. Scale bar: 100 μm. g FACS patterns of testicular cells in Prdm14mut/HV or Prdm14mut/+chimeric
rats with MAC rat ESCs. h Offspring generated by round spermatid injection (ROSI) of FACS-sorted MAC rat ESC-derived round spermatids into wild-type
rat oocytes. An arrowhead shows EGFP negative sibling.
Table 2 Injection of ESC-derived round spermatids into oocytes.
Donor spermatid Host oocyte No. (%) of oocytes No. (%) of pups
Origin Genotype Injected Survived Cleaved Transferred Born Fluorescence
Rat ESC MAC Slc:SD (Rat) 208 149 (72) 15 (10) 143 21 (15) 8 (38)
Mouse ESC Blimp1Tg(BAC-mEGFP)/+/CAG-
nmScarlet
Slc:BDF1 (Mouse) 87 72 (83) 38 (53) 68 20 (29) 20 (100)
Mouse iPSC CAG-EGFP Slc:BDF1 (Mouse) 173 169 (98) 153 (91) 162 37 (23) 16 (43)
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germline transmission in the absence of competition from host
germ cells.
Interspecific blastocyst complementation using Prdm14 KO rat
with mouse ESCs or iPSCs can generate functional mouse male
germ cells in rats. While rat PSCs can contribute to germline even
in wild-type mouse12,41,42, we hardly find mouse PGCs in rat
gonads in the presence of the host rat PGCs (Supplementary
Fig. 4b). Interestingly, at the onset of PGC specification and prior
to their migration toward gonads, a significant number of mouse
PGCs clustered with host rat PGCs in most of the Prdm14HV/+
rat chimeras (Supplementary Fig. 4a). Thus, these chimeras with a
high contribution of xenogenic cells might be eliminated due to
the abnormality often seen in the interspecific chimeras6,36, or
due to competition between mouse and rat PGCs, particularly in
nmScarletMerge+DAPI DAZL













































































































NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21557-x ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1328 | https://doi.org/10.1038/s41467-021-21557-x | www.nature.com/naturecommunications 7
the gonad where they proliferate actively. In any case, mouse
PSCs do not readily contribute to the germline in rats compared
with rat PSCs in the mouse. Previously, we demonstrated that the
contribution of xenogenic PSCs in interspecific chimeras between
mouse and rat varies greatly from organ to organ36. For instance,
in the kidney, rat PSCs contribute poorly to the metanephric
mesenchyme, the origin of renal parenchyma during embryonic
development, leading to failure in the generation of rat kidney in
Sall1 KO mouse7. Conversely, mouse kidneys are generated in the
Sall1 KO rat owing to the efficient contribution of mouse PSCs to
the metanephric mesenchyme10. Thus, the combination of the
species in chimera creation dictates the success of contribution to
the desired tissue or organ. Contribution to tissues such as the
neuron or the germline also requires careful consideration due to
ethical concerns when blastocyst complementation is applied to
human organ regeneration in livestock43. It is likely that such
contribution might be low or negligible, depending on the par-
ticular species used as host.
Interspecific chimeras between the mouse and rat are generally
smaller than intra-specific chimeras6,36. Thus, the greater evolu-
tionary distance between the donor and host species may limit the
extent of chimerism, which will affect the contribution to the
germline. However, the use of recipient embryos incapable of gen-
erating a host germline, such as in Prdm14 KO rats, increases the
likelihood of xenogenic germ cells even with PSCs that contribute
poorly to somatic tissues. Since in vitro reprogramming technology
enables PSCs derivation from endangered species44,45, the generation
of xenogenic germ cells in germline-deficient animals could provide a
useful approach to generate functional gametes for the preservation
of such species.
Taken together, blastocyst complementation in the germline
shown is a robust system for efficient generation of desired ani-
mals and xenogenic germ cells from PSCs.
Methods
Animals. Crlj:WI (RGD ID: 2312504) rats were purchased from Charles River
Laboratories Japan, Inc. (Kanagawa, Japan). Slc:SD (RGD ID: 12910483) rats,
C57BL/6NCrSlc, B6D2F1/Slc, and Slc:ICR mice were purchased from SLC Japan
(Shizuoka, Japan). All experiments were performed in accordance with the animal
care and use committee guidelines of the National Institute for Physiological
Sciences.
Culture of PSC lines. Undifferentiated rat ESCs　(WDB-Rosa26em1(RT2)Nips-
ES2/Nips, WDB/Nips-ES1/Nips, RGD ID: 10054010) were maintained on
mitomycin-C-treated mouse embryonic fibroblasts in N2B27 medium (all com-
ponents were purchased from Thermo Fisher Scientific, MA) containing 1 μM
PD0325901 (Axon, Groeningen, The Netherlands), 3 μM CHIR99021 (Axon), and
1000 U/ml of rat leukemia inhibitory factor (Millipore, Bedford, MA). A female
Rosa26tdTomato/tdTomato rat ESC line used in Figs. 1 and 2 was established from
blastocysts obtained from an intercross of Rosa26tdTomato/tdTomato rats (WDB-
ROSA26em1(RT2)Nips) according to published protocol46.
For making Pax2/Pax8 double KO rat ESCs, pX330-U6-Chimeric_BB-CBh-
hSpCas9 (Addgene plasmid # 42230) vectors expressing Cas9 protein with gRNA
target for coding sequence of Pax2 and Pax8 were introduced by reverse
transfection method using lipofectamine 2000 (Thermo Fisher Scientific) as
described before47. After transfection, we carried out limiting dilution to enrich
single cell-derived colonies and screened for mutants by PCR and subsequent
Sanger sequencing using the following primer sets: Pax2 (Fw, 5′- CCTCCATTT
TTCAGCTCTGC-3′, and Rv, 5′-CCCTCACTCCAAGTCTCAGC-3′), Pax8 (Fw,
5′-TCCCCAAATGGTGTGTTTCT-3′, and Rv, 5′- CGTTGGTGTTCCTT
GTCCTT-3′).
For making rat ESCs carrying MAC, MAC was transferred to rat ESCs via
microcell-mediated chromosome transfer28. Briefly, rat ESCs (BLK2i-1, RGD ID:
10054010) were fused with microcells prepared from the donor hybrid cells, and
selected with G418 (150 µg/mL). CHO cells containing a MAC with human
chromosome 21 region, which was developed previously48, was used as donor
hybrid cells in this study.
Undifferentiated mouse ESCs (established from Blimp1Tg(BAC-mEGFP)/+ mouse
in previous reports49,50) and mouse iPSCs (GT3.2 line6) were maintained on 0.1%
gelatin-coated plates in Ndiff227 medium (Takara Bio, Shiga, Japan) containing 1
μM PD0325901, 3 μM CHIR99021, 1,000 U/ml of mouse leukemia inhibitory
factor (Millipore), and 5% fetal calf serum (FCS, batch tested for mouse ESCs;
Thermo Fisher Scientific). To monitor the ESC-derived cells in chimeras, a
PiggyBac vector containing CAG-driven mScarlet with 3x nuclear localization
signals cassettes were transfected into mouse ESCs with PBase plasmid by reverse
transfection method. The transfected mouse ESCs were seeded on gelatin-coated
plates and 48 h later, 0.8 μg/ml puromycin (Sigma-Aldrich, MO) was added to the
culture medium for selection. Puromycin-resistant and nmScarlet positive mouse
ESC colonies were picked and used for the experiment.
Genotyping. To detect transgenes in germline transmitted pups or adults, genomic
DNA was analyzed by PCR using the following primer sets: tdTomato (Fw, 5′-GCG
AGGAGGTCATCAAAGAG-3′, and Rv, 5′-GATGACGGCCATGTTGTTGT-3′),
CAG-nmScarlet (Fw, 5′-GCCTCTGCTAACCATGTTCA-3′, and Rv, 5′-CTTGTAC
AGCTCGTCCATGCCG-3′), Blimp1-mEGFP (Fw, 5′-TAAACGGCCACAAGTT
CAGCG-3′, and Rv, 5′-CTCCTTGAAGTCGATGCCCTT-3′), CAG-EGFP
(Fw, 5′-GCCTCTGCTAACCATGTTCA-3′, and Rv, 5′-CTCCTTGAAGTCGATG
CCCTT-3′), pMXs-Oct3/4 (Fw, 5′-CCCTGGGGATGCTGTGAGCCAAGG-3′, and
Rv, 5′-CCCTTTTTCTGGAGACTAAATAAA-3′).
FISH analyses. The trypsinized rat ESCs and homogenized brain samples were
incubated for 15 min in 0.075M KCl, fixed with methanol and acetic acid (3:1), and
then slides were prepared using standard methods. FISH analyses were performed
using fixed metaphase spreads of each cell hybrid using digoxigenin-labeled
(Roche, Basel, Switzerland) DNA [mouse COT-1 DNA] and biotin-labeled DNA
[human COT-1 DNA (Invitrogen)]51. Chromosomal DNA was counterstained
with DAPI (Sigma-Aldrich). Images were captured using an AxioImagerZ2
fluorescence microscope (Carl Zeiss GmbH).
Embryo manipulation. A step-by-step protocol describing blastocyst com-
plementation can be found at our protocol published previously52.
For rat blastocyst injection, blastocysts were collected in mR1ECM medium
from the oviduct and uterus of rats at 4.5 days post coitum (dpc). For micro-
manipulation, rat or mouse ESCs were trypsinized and suspended in the ESC
medium, respectively. A piezo-driven micro-manipulator (Prime Tech, Tokyo,
Japan) was used to drill into the zona pellucida and trophectoderm under the
microscope and 7–8 rat ESCs were introduced into blastocyst cavities near the
Fig. 3 Interspecific blastocyst complementation in germline generates functional mouse spermatids in rats. a Schematics showing injection of mouse
ESCs or iPSCs into Prdm14-H2BVenus positive rat blastocysts. bWholemount immunostaining of the posterior part of Prdm14mut/HV chimeric embryo with
mouse ESCs at 6 days after embryo transfer (ET: embryonic day (E) 9–9.5). Dashed line shows cluster composed of H2BVenus expressing Prdm14mut/HV
rat PGCs and mEGFP/nmScarlet double-positive mouse PGCs. Scale bar: 50 μm. c Immunohistochemical staining of male gonads of Prdm14mut/HV
chimeric fetus at 12 days after ET (E15-15.5). mEGFP/nmScarlet/DAZL triple-positive mouse PGCs colonized in rat gonad. In contrast, no rat PGCs are
present due to defect in the Prdm14 gene. Scale bar: 50 μm. d Images of adult testis. The upper testis is a control testis from Prdm14mut/HV rat, and the
lower one is from Prdm14mut/HV chimeric rats with mouse ESCs. Scale bar: 5 mm. e Immunohistochemical staining of representative seminiferous tubules.
The tubules filled with nmScarlet positive cells show normal spermatogenesis originate from mouse ESC-derived germ cells. Scale bar: 50 μm. f Mouse
ESC-derived sperm collected from the epididymis of Prdm14mut/HV chimeric rats. Scale bar: 50 μm. g Postnatal day 3 neonates generated by ROSI of mouse
ESC-derived round spermatids into wild-type mouse oocytes. An open arrowhead shows control Slc:ICR neonate. h Images of the adult testis. The upper
testis is a control testis from Prdm14mut/HV rat, and the lower one is from Prdm14mut/HV chimeric rats with mouse iPSCs. Scale bar: 5 mm. i
Immunohistochemical staining of representative seminiferous tubules. The tubules filled with EGFP-positive cells show normal spermatogenesis originate
from mouse iPSC-derived germ cells. Scale bar: 50 μm. j Postnatal day 1 neonates generated by ROSI of mouse iPSC-derived round spermatids into wild-
type mouse oocytes. An open arrowhead shows control Slc:ICR neonate, and arrowheads show EGFP negative siblings. k A representative genotyping
result to detect the CAG-EGFP transgene and retroviral integration of a reprograming factor, pMXs-Oct3/4, used for the establishment of iPSCs.
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inner cell mass. After the injection, the blastocysts were transferred into the uterus
of pseudopregnant recipient Crlj:WI rats (3.5 dpc).
For mouse blastocyst injection, morula stage embryos were collected in KSOM
medium from oviduct and uterus of mice at 2.5 dpc, and then cultured for 1 day
until they reached the blastocyst stage. Mouse ESCs were trypsinized and
suspended in the ESC medium. As in the rat blastocyst injection, 7–8 mouse ESCs
were introduced into blastocyst cavities near the inner cell mass. After injection, the
blastocysts were transferred into the uterus of pseudopregnant recipient Slc:ICR
mice (2.5 dpc).
For rat ROSI, seminiferous tubules were dissociated mechanically and EGFP-
positive MAC rat ESC-derived rat round spermatids were collected with the SH800
cell sorter (SONY) according to a published protocol53. Sorted round spermatids
were suspended in PBS containing glucose, sodium lactate, and FCS and used as
donor cells. Metaphase II stage oocytes were collected in HEPES-KRB medium
from superovulated Slc:SD rats and denuded the cumulus with 0.1% hyaluronidase
treatment. Rat oocytes were then pretreated with 5 mM ionomycin for 5 min and
incubated for 40 min in mKRB medium until injection. After ROSI, the fertilized
embryos were treated for 4 h with 5 µg/mL cycloheximide (Sigma-Aldrich) in
mKRB. After follow-up incubation in mKRB for 1 day, embryos were transferred
into the oviduct of pseudo-pregnant Crlj:WI rats.
For mouse ROSI, nmScarlet positive mouse ESC-derived mouse round
spermatids were collected with the SH800 cell sorter and used as donor cells.
Metaphase II stage oocytes were collected in CZB medium from B6D2F1/Slc mice
and denuded the cumulus with 0.1% hyaluronidase treatment. Before ROSI, mouse
oocytes were treated with 10 mM SrCl2 for 20 min. After follow-up incubation of
the mouse embryos in CZB for 1 day, embryos were transferred into the oviduct of
pseudo-pregnant Slc:ICR mice.
Histological analysis. Tissues were fixed in 4% PFA for 4 h to O/N at RT
depending on the size. Whole embryos and embryonic gonads were fixed in 4%
PFA for 30 min at RT or for 6 h at 4 °C. For cryosections, the fixed embryos were
embedded in OCT compound. Each sample was incubated with primary antibodies
for 1–2 h at RT or O/N at RT or 4 °C, and then with fluorescent-conjugated
secondary antibodies with DAPI (FUJIFILM Wako, Osaka, Japan) for 1 h at RT or
O/N at 4 °C. Antibodies used here are listed in Supplementary Table 2. The
embryos and cryosections were observed under confocal laser scanning microscopy
(FV3000; Olympus, Tokyo, Japan). For imaging, we carefully performed all the
experiments with appropriate controls. To judge positive fluorescent signals, we
obtained the images alongside samples of chimera or non-chimera that have partial
or no contribution of donor cells.
Progeny testing to confirm germline transmission of Rosa26tdTomato/tdTomato
rat ESCs. Chimeric rats generated by injection of male or female
Rosa26tdTomato/tdTomato rat ESCs were crossed with Crlj:WI (RGD ID:
2312504) rats. Since ESCs are homozygous for Rosa26-tdTomato, all the pups
with germline transmission ubiquitously express tdTomato fluorescence in all
the tissues. In addition, since rat ESCs originate from WDB/Nips black rat
(RGD ID: 7411634), the resulting pups from germline transmission of the rat
ESCs also clearly show black coat color and black eye by the effect of the
dominant gene. Thus, we judged the number of pups resulting from the
germline transmission of tdTomato fluorescence, and the coat and eye color
appearance.
Blood chimerism analysis. Peripheral blood samples obtained from each chimera
were hemolyed by red blood cell lysis buffer. After washing the cells with PBS
containing 3% FCS, the percentage of donor PSC-derived cells were determined by
fluorescent signals in the blood cells detected by SH800 cell sorter.
Data reproducibility. IF images in Figs. 1d, f, 2b, f, 3b, c, e, i, Supplementary
Figs. 2b,d, 3b,c, 4a,b were representatives of multiple sections at different projec-
tions (6<). Karyotyping images in Fig. 2d and Supplementary Fig. 1c were repre-
sentatives obtained from multiple cells on each slide. Image in Fig. 3f is
representative of two animals. Genotyping in Fig. 3k, Supplementary Figs. 1a and
3h was performed one time with appropriate loading controls.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within
the article and its supplementary information files or from the corresponding author
upon reasonable request. Source data are provided with this paper.
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